AI-based Anomaly Detection for Clinical-Grade Histopathological Diagnostics

Fuente: arXiv
Salvato in:
Dettagli Bibliografici
Autori principali: Dippel, Jonas, Prenißl, Niklas, Hense, Julius, Liznerski, Philipp, Winterhoff, Tobias, Schallenberg, Simon, Kloft, Marius, Buchstab, Oliver, Horst, David, Alber, Maximilian, Ruff, Lukas, Müller, Klaus-Robert, Klauschen, Frederick
Natura: Preprint
Pubblicazione: 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866929393781178368
author Dippel, Jonas
Prenißl, Niklas
Hense, Julius
Liznerski, Philipp
Winterhoff, Tobias
Schallenberg, Simon
Kloft, Marius
Buchstab, Oliver
Horst, David
Alber, Maximilian
Ruff, Lukas
Müller, Klaus-Robert
Klauschen, Frederick
author_facet Dippel, Jonas
Prenißl, Niklas
Hense, Julius
Liznerski, Philipp
Winterhoff, Tobias
Schallenberg, Simon
Kloft, Marius
Buchstab, Oliver
Horst, David
Alber, Maximilian
Ruff, Lukas
Müller, Klaus-Robert
Klauschen, Frederick
contents While previous studies have demonstrated the potential of AI to diagnose diseases in imaging data, clinical implementation is still lagging behind. This is partly because AI models require training with large numbers of examples only available for common diseases. In clinical reality, however, only few diseases are common, whereas the majority of diseases are less frequent (long-tail distribution). Current AI models overlook or misclassify these diseases. We propose a deep anomaly detection approach that only requires training data from common diseases to detect also all less frequent diseases. We collected two large real-world datasets of gastrointestinal biopsies, which are prototypical of the problem. Herein, the ten most common findings account for approximately 90% of cases, whereas the remaining 10% contained 56 disease entities, including many cancers. 17 million histological images from 5,423 cases were used for training and evaluation. Without any specific training for the diseases, our best-performing model reliably detected a broad spectrum of infrequent ("anomalous") pathologies with 95.0% (stomach) and 91.0% (colon) AUROC and generalized across scanners and hospitals. By design, the proposed anomaly detection can be expected to detect any pathological alteration in the diagnostic tail of gastrointestinal biopsies, including rare primary or metastatic cancers. This study establishes the first effective clinical application of AI-based anomaly detection in histopathology that can flag anomalous cases, facilitate case prioritization, reduce missed diagnoses and enhance the general safety of AI models, thereby driving AI adoption and automation in routine diagnostics and beyond.
format Preprint
id arxiv_https___arxiv_org_abs_2406_14866
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle AI-based Anomaly Detection for Clinical-Grade Histopathological Diagnostics
Dippel, Jonas
Prenißl, Niklas
Hense, Julius
Liznerski, Philipp
Winterhoff, Tobias
Schallenberg, Simon
Kloft, Marius
Buchstab, Oliver
Horst, David
Alber, Maximilian
Ruff, Lukas
Müller, Klaus-Robert
Klauschen, Frederick
Artificial Intelligence
Image and Video Processing
While previous studies have demonstrated the potential of AI to diagnose diseases in imaging data, clinical implementation is still lagging behind. This is partly because AI models require training with large numbers of examples only available for common diseases. In clinical reality, however, only few diseases are common, whereas the majority of diseases are less frequent (long-tail distribution). Current AI models overlook or misclassify these diseases. We propose a deep anomaly detection approach that only requires training data from common diseases to detect also all less frequent diseases. We collected two large real-world datasets of gastrointestinal biopsies, which are prototypical of the problem. Herein, the ten most common findings account for approximately 90% of cases, whereas the remaining 10% contained 56 disease entities, including many cancers. 17 million histological images from 5,423 cases were used for training and evaluation. Without any specific training for the diseases, our best-performing model reliably detected a broad spectrum of infrequent ("anomalous") pathologies with 95.0% (stomach) and 91.0% (colon) AUROC and generalized across scanners and hospitals. By design, the proposed anomaly detection can be expected to detect any pathological alteration in the diagnostic tail of gastrointestinal biopsies, including rare primary or metastatic cancers. This study establishes the first effective clinical application of AI-based anomaly detection in histopathology that can flag anomalous cases, facilitate case prioritization, reduce missed diagnoses and enhance the general safety of AI models, thereby driving AI adoption and automation in routine diagnostics and beyond.
title AI-based Anomaly Detection for Clinical-Grade Histopathological Diagnostics
topic Artificial Intelligence
Image and Video Processing
url https://arxiv.org/abs/2406.14866